All you need to know about gastrinoma today | Gastrinoma and Zollinger‐Ellison syndrome: A thorough update
Journal of Neuroendocrinology · 2023-04 · 35 (4)
DOI: 10.1111/jne.13267 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 11.04.2023. Verfasst von Odysseas Chatzipanagiotou und 7 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece. Hauptthemen laut MEDLINE: Zollinger-Ellison Syndrome, Gastrinoma, Multiple Endocrine Neoplasia Type 1. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 98 Literaturangaben.
Abstract (Originalsprache)
Zollinger‐Ellison syndrome (ZES) is a distinct syndrome characterized by hyperchlorhydria‐induced peptic ulcer disease and chronic diarrhea. It is the result of a gastrin‐excess state caused by a duodenal or pancreatic neuroendocrine tumor referred to as gastrinoma. This gastrin‐secreting neuroendocrine tumor is usually sporadic in nature, or part of multiple endocrine neoplasia type 1 syndrome. The high rate of malignancy associated with gastrinomas substantiates the need for early diagnosis. In order to diagnose ZES with laboratory tests, patients under antacid medication are required to stay off proton pump inhibitors for at least one week and H2 receptor antagonists for 48 h. Fasting serum gastrin level measurement serves as an initial and fundamental diagnostic test, boasting a sensitivity of 99%. Gastrinoma patients will present with a gastrin level greater than 100 pg/mL, while a serum gastrin level higher than 1000 pg/mL, in the presence of gastric pH
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Department of Surgery, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
- First Propaedeutic Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
ORCID-Profile: Michail Vailas, Marina Tsoli
Zitieren
APA
Chatzipanagiotou, O., Schizas, D., Vailas, M., Tsoli, M., Sakarellos, P., Sotiropoulou, M., Papalambros, A., & Felekouras, E. (2023). All you need to know about gastrinoma today | Gastrinoma and Zollinger‐Ellison syndrome: A thorough update. Journal of Neuroendocrinology, 35(4). https://doi.org/10.1111/jne.13267
Vancouver
Chatzipanagiotou O, Schizas D, Vailas M, Tsoli M, Sakarellos P, Sotiropoulou M, et al. All you need to know about gastrinoma today | Gastrinoma and Zollinger‐Ellison syndrome: A thorough update. Journal of Neuroendocrinology. 2023;35(4). doi:10.1111/jne.13267
BibTeX
@article{Chatzipanagiotou2023,
author = {Chatzipanagiotou, Odysseas and Schizas, Dimitrios and Vailas, Michail and Tsoli, Marina and Sakarellos, Panagiotis and Sotiropoulou, Maria and Papalambros, Alexandros and Felekouras, Evangellos},
title = {All you need to know about gastrinoma today | Gastrinoma and Zollinger‐Ellison syndrome: A thorough update},
journal = {Journal of Neuroendocrinology},
year = {2023},
volume = {35},
number = {4},
doi = {10.1111/jne.13267}
}
EUVIMED